Group 1 - The core viewpoint of the news is that Meihao Medical has seen a stock price increase of 5.15%, reaching 23.87 CNY per share, with a trading volume of 259 million CNY and a turnover rate of 2.95%, resulting in a total market capitalization of 13.579 billion CNY [1] - Meihao Medical, established on July 15, 2010, and listed on October 12, 2022, is located in Longgang District, Shenzhen, Guangdong Province, and specializes in the design, development, manufacturing, and sales of precision components and products for medical devices [1] - The main revenue composition of Meihao Medical includes: 59.48% from home respiratory machine components, 14.61% from home and consumer electronics components, 10.33% from other medical product components, 8.16% from cochlear implant components, 5.63% from precision molds and automation equipment, 1.09% from other categories, and 0.70% from proprietary products [1] Group 2 - From the perspective of Meihao Medical's top ten circulating shareholders, Huabao Fund holds a position in the top ten shareholders, having reduced its holdings by 881,300 shares to 4.8127 million shares, which represents 3.08% of the circulating shares [2] - The Huabao Zhongzheng Medical ETF (512170), established on May 20, 2019, has a latest scale of 26.404 billion CNY, with a year-to-date return of 5.39% and a one-year return of 1.8% [2] - The fund manager of Huabao Zhongzheng Medical ETF is Hu Jie, who has a cumulative tenure of 13 years and 74 days, managing total assets of 100.204 billion CNY, with the best fund return during the tenure being 177.89% and the worst being -98.01% [2]
美好医疗股价涨5.15%，华宝基金旗下1只基金位居十大流通股东，持有481.27万股浮盈赚取563.08万元